U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
105631105631Efficacy and Safety of DEB025 Combined With Peg-IFN Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 1 Relapsers and Non-respondersCompletedNo Results AvailableHepatitis C ChronicDrug: DEB025 600 mg QD + PegIFN + RBV|Drug: DEB025 800 mg QD + PegIFN + RBV|Drug: placebo + PegIFN + RBV|Drug: placebo + PegIFN + RBV|Drug: DEB025 400 mg BID + PegIFN + RBVhttps://ClinicalTrials.gov/show/NCT01183169
105632105632Re-invitation to Screening Colonoscopy: a Randomized StudyRecruitingNo Results AvailableColorectal Cancer|Screening|Patient ParticipationBehavioral: Re-invitation letter|Behavioral: Invitation to educational meetinghttps://ClinicalTrials.gov/show/NCT01183156
105633105633Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro FertilizationCompletedNo Results AvailableInfertility|Ovulation Induction|In-Vitro FertilizationDrug: Follitropin alpha (Gonal-F)https://ClinicalTrials.gov/show/NCT01183143
105634105634Compliance Monitoring in Real Time During Opioid Substitution TreatmentWithdrawnNo Results AvailableOpiate DependenceDevice: Compliance monitoring with electronic devicehttps://ClinicalTrials.gov/show/NCT01183130
105635105635A Clinical Investigation of SM-01 Stenting Versus PTA for the Treatment of Superficial Femoral Artery DiseaseCompletedNo Results AvailablePeripheral Vascular DiseasesDevice: SM-01|Device: PTAhttps://ClinicalTrials.gov/show/NCT01183117
105636105636START-J: SiTAgliptin in eldeRly Trial in JapanCompletedNo Results AvailableType 2 DiabetesDrug: Sitagliptin, Glimepiridehttps://ClinicalTrials.gov/show/NCT01183104
105637105637Medical Economical Evaluation of the Ablation by Catheter of the Atrial Tissue in the Treatment of AFCompletedNo Results AvailableAtrial FibrillationProcedure: Ablation of atrial fibrillationhttps://ClinicalTrials.gov/show/NCT01183091
105638105638Distal Locking Using an Electromagnetic Field Guided Computer Based Real Time System for Orthopaedic Trauma PatientsCompletedNo Results AvailableTibial Fractures|Femoral FracturesProcedure: free-hand|Procedure: Wand techniquehttps://ClinicalTrials.gov/show/NCT01183078
105639105639Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)CompletedNo Results AvailableHead and Neck CancerDrug: Pralatrexate With Vitamin B12 and Folic Acidhttps://ClinicalTrials.gov/show/NCT01183065
105640105640Mitochondrial Dysfunction and Oxidative Stress in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNo Results AvailableCOPD PatientsOther: Traininghttps://ClinicalTrials.gov/show/NCT01183052
105641105641Effects of Training in Healthy Sedentary SubjectsCompletedNo Results AvailableSedentary SubjectsOther: Traininghttps://ClinicalTrials.gov/show/NCT01183039
105642105642V/Q SPECT for Diagnosis of Pulmonary EmbolismCompletedNo Results AvailablePulmonary Embolismhttps://ClinicalTrials.gov/show/NCT01183026
10564310564330 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by a Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes for up to 54 WeeksCompletedHas ResultsDiabetes Mellitus, Type 2Drug: Pioglitazone 15 mg|Drug: Pioglitazone 45 mg|Drug: Pioglitazone 30 mg|Drug: Linagliptin 5mg / Pioglitazone 45 mg FDC|Drug: Linagliptin 5mg / Pioglitazone 30 mg FDC|Drug: Linagliptin 5mg|Drug: Linagliptin 5mg / Pioglitazone 15 mg FDChttps://ClinicalTrials.gov/show/NCT01183013
105644105644Closure of Peritoneum at Cesarean Section and Postoperative AdhesionCompletedNo Results AvailableCesarean Section|AdhesionsProcedure: Closure of the peritoneum at cshttps://ClinicalTrials.gov/show/NCT01183000
105645105645SCAN Memory Program Evaluation StudyRecruitingNo Results AvailableDementiaBehavioral: Dementia Care Managementhttps://ClinicalTrials.gov/show/NCT01182987
105646105646Paracetamol Toxicity in Septic PatientsSuspendedNo Results AvailableFever|SepsisDrug: paracetamol|Drug: dypironehttps://ClinicalTrials.gov/show/NCT01182974
105647105647The Use of Virtual Reality for the Gait Training of Elderly FallersNot yet recruitingNo Results AvailableElderlyOther: gait training|Other: gait training 2|Other: exercise grouphttps://ClinicalTrials.gov/show/NCT01182961
105648105648Effects of Different Types of Exercise in Type 2 DiabetesCompletedNo Results AvailableType 2 DiabetesBehavioral: Aerobic Training|Behavioral: Resistance Traininghttps://ClinicalTrials.gov/show/NCT01182948
105649105649Elevated Triglyceride Levels and Later Type 2 DiabetesCompletedNo Results AvailableType 2 Diabeteshttps://ClinicalTrials.gov/show/NCT01182935
105650105650Information About a Doctor or a Possibility of Choosing Doctor's Gender and Attendance to Screening ColonoscopyCompletedNo Results AvailableColorectal Cancer|ScreeningBehavioral: Invitation letterhttps://ClinicalTrials.gov/show/NCT01182922
105651105651Environmental and Genetic Determinants of Nasopharyngeal Carcinoma (NPC)RecruitingNo Results AvailableNasopharyngeal Carcinomahttps://ClinicalTrials.gov/show/NCT01182909
105652105652A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid TumorsWithdrawnNo Results AvailableBrain Stem Neoplasms|Glioma|PinealomaDrug: IMC-A12|Drug: Temsirolimushttps://ClinicalTrials.gov/show/NCT01182883
105653105653Vitamin D and the Influenza EpidemicCompletedNo Results AvailableInfluenzaDrug: choleclaciferolhttps://ClinicalTrials.gov/show/NCT01182870
105654105654Quality of Life and Neuropsychiatric Sequelae in Patients Treated With Gene Therapy for ADA-SCID and in Their ParentsWithdrawnNo Results AvailableADA-SCIDhttps://ClinicalTrials.gov/show/NCT01182857
105655105655Obesity - Inflammation - Metabolic Disease: Effect of Lactobacillus Casei ShirotaCompletedNo Results AvailableMetabolic SyndromeDietary Supplement: Lactobacillus casei Shirotahttps://ClinicalTrials.gov/show/NCT01182844
105656105656Trial Comparing Two Techniques of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma PancreasRecruitingNo Results AvailablePancreatic CancerProcedure: percutaneous fluoro guided celiac plexus neurolysis|Procedure: EUS guided neurolysishttps://ClinicalTrials.gov/show/NCT01182831
105657105657Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry DiseaseCompletedNo Results AvailableCerebrovascular Accident|Stroke, Acute|Cerebral Strokehttps://ClinicalTrials.gov/show/NCT01182818
105658105658Radiofrequency-based Speckle Tracking Echocardiography to Evaluate Diastolic FunctionCompletedHas ResultsHeart Failure, DiastolicDevice: Echocardiography system Ultra DCI Model 5000|Device: Echocardiography machine GE Vivid E9|Device: Diastolic function assessmenthttps://ClinicalTrials.gov/show/NCT01182805
105659105659Chronic Mountain Sickness, Systemic Vascular FunctionActive, not recruitingNo Results AvailableMountain Sickness|ChronicDietary Supplement: Vitamin C and E|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT01182792
105660105660Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Chordoma of the Skull BaseRecruitingNo Results AvailableChordoma|Tumor|TreatmentRadiation: Carbon ion|Radiation: Protonshttps://ClinicalTrials.gov/show/NCT01182779

* Görseller ve İçerik tekif hakkına sahip olabilir